Former Genzyme executive Vivaldi replaced as CEO of Minerva (Video)
November 25, 2014 at 08:48 AM EST
Minerva Neurosciences, a biotech focused on drugs to treat schizophenia, has replaced the former Genzyme executive who brought the company public this past May, Rogerio Vivaldi...
